Other
Accrued Research And Development Expenses
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ4 2024
Last reportedQ4 2024Mar 24, 2026
How to read this metric
An increase suggests active, ongoing R&D projects, while a decrease might indicate a slowdown in research activity.
Detailed definition
Liabilities recognized for research and development services that have been performed but not yet invoiced or paid. This...
Peer comparison
Common in biotech companies; reflects the intensity of clinical trial and laboratory operations.
Metric ID:
other_accrued_research_and_development_expensesHistorical Data
1 periods
| Q4 '24 | |
|---|---|
| Value | $86K |
Accrued Research And Development Expenses at Other Companies
Frequently Asked Questions
- What is Polaryx Therapeutics, Inc. 's accrued research and development expenses?
- Polaryx Therapeutics, Inc. (PLYX) reported accrued research and development expenses of $86K in Q4 2024.
- What does accrued research and development expenses mean?
- Money owed for research and development work that has been completed but not yet paid.